XGENERA LTD

Active Southampton

Other research and experimental development on natural sciences and engineering

6 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
X

XGENERA LTD

Other research and experimental development on natural sciences and engineering

Founded 24 May 2023 Active Southampton, England 6 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 1 Aug 2025 Next due 31 Jan 2027 7 months remaining
Confirmation Submitted 28 May 2026 Next due 6 Jun 2027 11 months remaining
Net assets £976K £977K 2025 year on year
Total assets £1M £1M 2025 year on year
Total Liabilities £74K £73K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

313 Calmore Road Calmore Southampton SO40 2RF England

Website

www.example.com

Full company profile for XGENERA LTD (14891840), an active life sciences and medical technology company based in Southampton, England. Incorporated 24 May 2023. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type total-exemption-full
Next accounts 30 Apr 2026
Due by 31 Jan 2027 7 months remaining

Net Assets, Total Assets & Total Liabilities (2024–2025)

Cash in Bank

£914.12k

Increased by £914.09k (+3264611%)

Net Assets

£976.07k

Increased by £976.88k (+120306%)

Total Liabilities

£74.04k

Increased by £73.20k (+8714%)

Turnover

N/A

Employees

6

Debt Ratio

7%

Decreased by 2993 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 352,931 Shares £1.06m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Nov 202464,598£563k£8.72
16 Oct 202428,670£250k£8.72
9 Sept 202411,468£100k£8.72
5 Sept 202417,201£148k£8.62
3 Sept 2024105,994£4.24£0

Officers

Officers

3 active
Status
Haycock, Richard IanDirectorBritishEngland733 Sept 2024Active
Shapanis, Andrew George, DrDirectorBritishEngland3324 May 2023Active
Skipp, Paul James Stuart, ProfessorDirectorBritishEngland5524 May 2023Active

Shareholders

Shareholders (8)

Andrew Shapanis
44.0%
375,000
Paul Skipp
29.3%
250,000

Persons with Significant Control

Persons with Significant Control (4)

4 Active

Andrew George Shapanis

British

Active
Notified 24 May 2023
Residence England
DOB January 1993
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Professor Paul James Stuart Skipp

British

Active
Notified 24 May 2023
Residence England
DOB March 1971
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Professor Paul James Stuart Skipp

British

Active
Notified 24 May 2023
Residence England
DOB March 1971
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Dr Andrew George Shapanis

British

Active
Notified 24 May 2023
Residence England
DOB January 1993
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 May 2026Confirmation StatementConfirmation statement made on 23 May 2026 with no updates
1 Aug 2025AccountsAnnual accounts made up to 30 Apr 2025
6 Jun 2025ResolutionResolutions
5 Jun 2025CapitalAllotment of shares (GBP 34.11724) on 27 Nov 2024
5 Jun 2025Confirmation StatementConfirmation statement made on 23 May 2025 with updates
28 May 2026 Confirmation Statement

Confirmation statement made on 23 May 2026 with no updates

1 Aug 2025 Accounts

Annual accounts made up to 30 Apr 2025

6 Jun 2025 Resolution

Resolutions

5 Jun 2025 Capital

Allotment of shares (GBP 34.11724) on 27 Nov 2024

5 Jun 2025 Confirmation Statement

Confirmation statement made on 23 May 2025 with updates

Recent Activity

Latest Activity

Confirmation statement made on 23 May 2026 with no updates

2 weeks ago on 28 May 2026

Annual accounts made up to 30 Apr 2025

10 months ago on 1 Aug 2025

Resolutions

1 years ago on 6 Jun 2025

Allotment of shares (GBP 34.11724) on 27 Nov 2024

1 years ago on 5 Jun 2025

Confirmation statement made on 23 May 2025 with updates

1 years ago on 5 Jun 2025